Antisense Oligonucleotide Therapeutics Market By Type, Application, Key Players and Regions - Global Industry Analysis & Forecast to 2027
Published On : August 2022 Pages : 135 Category: Automotive Report Code : AT0817446
The global Antisense Oligonucleotide Therapeutics Market is valued at USD XX billion in 2021 and is projected to reach USD XX billion by the end of 2027, growing at a CAGR of XX% during the period 2022 to 2027.
The report exhibit detail coverage of Antisense Oligonucleotide Therapeutics industry and market trends. The report also analyses present and past market values to forecast potential market through the forecast period between 2017-2022. This research study of Antisense Oligonucleotide Therapeutics Market involved the extensive usage of both primary and secondary data sources. This includes the study of various parameters affecting the industry, including the government policy, market environment, competitive landscape, historical data, present trends in the market, technological innovation, upcoming technologies and the technical progress in related industry.
In addition, the report provides insight into main drivers, challenges, opportunities and risk of the market and strategies of suppliers. Key players are profiled as well. Overall, this report covers the historical situation, present status and the future prospects of the global Antisense Oligonucleotide Therapeutics Market for 2017-2027.
Crystal Market Research envisions that the span of the Antisense Oligonucleotide Therapeutics Market will develop amid the estimated time frame as the Compound Annual Growth Rate boosts significantly. The objective of the market research report is the current status of the market and in accordance classifies it into a few portions. The report takes into consideration the prime market players in every area from over the globe.
Our research study analyses the size of the global market of Antisense Oligonucleotide Therapeutics in primary regions such as North America, South America, Middle East & Africa, Asia Pacific and Europe. It also classifies the Antisense Oligonucleotide Therapeutics Market by key manufacturers, region, type and application. Furthermore, this study examines in the status of the market, market share, future trends, growth rate, competitive landscape, opportunities, market driving factors and restraints, and challenges.
To stay updated with the latest technology and functions of the industry, Crystal Market Research regularly performs interviews with several industry experts and visits for its expert research analysts. The data sources include but not limited to reports of company’s, international organizations and governments, MMI market surveys, and related industry news.
This report forecasts revenue growth at global, regional & country levels and provides an analysis on the industry trends in each of the sub-segments from 2017 to 2027. This report has segmented the Antisense Oligonucleotide Therapeutics Market on the basis of fabric, product, application, and region:
Competitive Analysis
The major players in the market are profiled in detail in view of qualities, for example, company portfolio, business strategies, financial overview, recent developments, and share of the overall industry.
- Ionis Pharmaceuticals, Inc
- Sarpeta Therapeutics Inc.
- Biogen Inc
- Alnylam Pharmaceuticals, Inc
- Antisense Therapeutics Limited
- Arrowhead Pharmaceuticals Inc.
- Enzon Pharmaceuticals, Inc
- Bio-Path Holdings, Inc
- GlaxoSmithKline PLC
- Geron Corporation (Geron)
- Sarpeta Therapeutics Inc
Market Classification
· Antisense Oligonucleotide Therapeutics Market, By Type
o Pulmonary Delivery
o Intravenous Injections
o Intradermal Injections
o Intraperitoneal Injections
o Topical Delivery
o Others
· Antisense Oligonucleotide Therapeutics Market, By Application
o Electrical & Electronics
o Automobiles
o Solar & Wind Energy Systems
o Others
o Genetic Disorders
o oNeurological Disorders
o Oncological Disorders
o Metabolic Disorders
o Ophthalmic Disorders
By Region
- North America (US, Canada)
- Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
- Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
- South America (Brazil, Mexico, Columbia, Rest of South America)
- Middle East and Africa (Saudi Arabia, UAE, South Africa, Turkey, Rest of MEA)
Years considered for this report:
Historical Years: 2017-2021
Base Year: 2021
Estimated Year: 2022
Forecast Period: 2022-2027
Some of the key questions answered by the report are:
- What was the market size in 2017 and forecast from 2022 to 2027?
- What will be the industry market growth from 2017 to 2027?
- What are the major drivers, restraints, opportunities, challenges, and industry trends and their impact on the market forecast?
- What are the major segments leading the market growth and why?
- Which are the leading players in the market and what are the major strategies adopted by them to sustain the market competition?
Table of Contents
1. Introduction
1.1. Report Description
1.2. Research Methodology
1.2.1. Data Mining
1.2.2. Market Modeling and Forecasting
1.2.3. Data Validation
1.2.4. Industry Analysis
2. Market Dashboard
3. Market Overview
3.1. Introduction
3.1.1. Market Definition
3.1.2. Market Segmentation
3.2. Market Dynamics
3.2.1. Drivers
3.2.2. Restraints
3.2.3. Opportunities
3.2.4. Challenges
4. Antisense Oligonucleotide Therapeutics Market, By Type
4.1. Introduction
4.2. Antisense Oligonucleotide Therapeutics Market and Market Growth Rate By Type (2017-2022)
4.3. Pulmonary Delivery
4.3.1. Global Pulmonary Delivery Market and Growth Rate (2017-2022)
4.3. Intravenous Injections
4.3.1. Global Intravenous Injections Market and Growth Rate (2017-2022)
4.3. Intradermal Injections
4.3.1. Global Intradermal Injections Market and Growth Rate (2017-2022)
4.3. Intraperitoneal Injections
4.3.1. Global Intraperitoneal Injections Market and Growth Rate (2017-2022)
4.3. Topical Delivery
4.3.1. Global Topical Delivery Market and Growth Rate (2017-2022)
4.3. Others
4.3.1. Global Others Market and Growth Rate (2017-2022)
5. Antisense Oligonucleotide Therapeutics Market, By Application
5.1. Introduction
5.2. Antisense Oligonucleotide Therapeutics Market and Market Growth Rate By Application (2017-2022)
5.3. Electrical & Electronics
5.3.1. Global Electrical & Electronics Market and Growth Rate (2017-2022)
5.3. Automobiles
5.3.1. Global Automobiles Market and Growth Rate (2017-2022)
5.3. Solar & Wind Energy Systems
5.3.1. Global Solar & Wind Energy Systems Market and Growth Rate (2017-2022)
5.3. Others
5.3.1. Global Others Market and Growth Rate (2017-2022)
5.3. Genetic Disorders
5.3.1. Global Genetic Disorders Market and Growth Rate (2017-2022)
5.3. oNeurological Disorders
5.3.1. Global oNeurological Disorders Market and Growth Rate (2017-2022)
5.3. Oncological Disorders
5.3.1. Global Oncological Disorders Market and Growth Rate (2017-2022)
5.3. Metabolic Disorders
5.3.1. Global Metabolic Disorders Market and Growth Rate (2017-2022)
5.3. Ophthalmic Disorders
5.3.1. Global Ophthalmic Disorders Market and Growth Rate (2017-2022)
7. Antisense Oligonucleotide Therapeutics Market, By Region
7.1. Introduction
7.2. Antisense Oligonucleotide Therapeutics Market and Growth Rate By Regions
6.3. North America
7.3.1. North America Antisense Oligonucleotide Therapeutics Market and Growth Rate (2017-2022))
7.3.2. North America Antisense Oligonucleotide Therapeutics Market By Type (2017-2022)
7.3.2. North America Antisense Oligonucleotide Therapeutics Market By Application (2017-2022)
7.3.4. North America Antisense Oligonucleotide Therapeutics Market By Country (2017-2022)
7.3.5. United States
7.3.5.1.United States Antisense Oligonucleotide Therapeutics Market and Growth Rate (2017-2022)
7.3.5.2.United States Antisense Oligonucleotide Therapeutics Market By Type (2017-2022)
7.3.5.2.United States Antisense Oligonucleotide Therapeutics Market By Application (2017-2022)
7.3.5. Canada
7.3.5.1.Canada Antisense Oligonucleotide Therapeutics Market and Growth Rate (2017-2022)
7.3.5.2.Canada Antisense Oligonucleotide Therapeutics Market By Type (2017-2022)
7.3.5.2.Canada Antisense Oligonucleotide Therapeutics Market By Application (2017-2022)
6.3. Europe
8.3.1. Europe Antisense Oligonucleotide Therapeutics Market and Growth Rate (2017-2022))
8.3.2. Europe Antisense Oligonucleotide Therapeutics Market By Type (2017-2022)
8.3.2. Europe Antisense Oligonucleotide Therapeutics Market By Application (2017-2022)
8.3.4. Europe Antisense Oligonucleotide Therapeutics Market By Country (2017-2022)
8.3.5. Germany
8.3.5.1.Germany Antisense Oligonucleotide Therapeutics Market and Growth Rate (2017-2022)
8.3.5.2.Germany Antisense Oligonucleotide Therapeutics Market By Type (2017-2022)
8.3.5.2.Germany Antisense Oligonucleotide Therapeutics Market By Application (2017-2022)
8.3.5. France
8.3.5.1.France Antisense Oligonucleotide Therapeutics Market and Growth Rate (2017-2022)
8.3.5.2.France Antisense Oligonucleotide Therapeutics Market By Type (2017-2022)
8.3.5.2.France Antisense Oligonucleotide Therapeutics Market By Application (2017-2022)
8.3.5. UK
8.3.5.1.UK Antisense Oligonucleotide Therapeutics Market and Growth Rate (2017-2022)
8.3.5.2.UK Antisense Oligonucleotide Therapeutics Market By Type (2017-2022)
8.3.5.2.UK Antisense Oligonucleotide Therapeutics Market By Application (2017-2022)
8.3.5. Russia
8.3.5.1.Russia Antisense Oligonucleotide Therapeutics Market and Growth Rate (2017-2022)
8.3.5.2.Russia Antisense Oligonucleotide Therapeutics Market By Type (2017-2022)
8.3.5.2.Russia Antisense Oligonucleotide Therapeutics Market By Application (2017-2022)
8.3.5. Italy
8.3.5.1.Italy Antisense Oligonucleotide Therapeutics Market and Growth Rate (2017-2022)
8.3.5.2.Italy Antisense Oligonucleotide Therapeutics Market By Type (2017-2022)
8.3.5.2.Italy Antisense Oligonucleotide Therapeutics Market By Application (2017-2022)
8.3.5. Rest of Europe
8.3.5.1.Rest of Europe Antisense Oligonucleotide Therapeutics Market and Growth Rate (2017-2022)
8.3.5.2.Rest of Europe Antisense Oligonucleotide Therapeutics Market By Type (2017-2022)
8.3.5.2.Rest of Europe Antisense Oligonucleotide Therapeutics Market By Application (2017-2022)
6.3. Asia-Pacific
9.3.1. Asia-Pacific Antisense Oligonucleotide Therapeutics Market and Growth Rate (2017-2022))
9.3.2. Asia-Pacific Antisense Oligonucleotide Therapeutics Market By Type (2017-2022)
9.3.2. Asia-Pacific Antisense Oligonucleotide Therapeutics Market By Application (2017-2022)
9.3.4. Asia-Pacific Antisense Oligonucleotide Therapeutics Market By Country (2017-2022)
9.3.5. China
9.3.5.1.China Antisense Oligonucleotide Therapeutics Market and Growth Rate (2017-2022)
9.3.5.2.China Antisense Oligonucleotide Therapeutics Market By Type (2017-2022)
9.3.5.2.China Antisense Oligonucleotide Therapeutics Market By Application (2017-2022)
9.3.5. Japan
9.3.5.1.Japan Antisense Oligonucleotide Therapeutics Market and Growth Rate (2017-2022)
9.3.5.2.Japan Antisense Oligonucleotide Therapeutics Market By Type (2017-2022)
9.3.5.2.Japan Antisense Oligonucleotide Therapeutics Market By Application (2017-2022)
9.3.5. Korea
9.3.5.1.Korea Antisense Oligonucleotide Therapeutics Market and Growth Rate (2017-2022)
9.3.5.2.Korea Antisense Oligonucleotide Therapeutics Market By Type (2017-2022)
9.3.5.2.Korea Antisense Oligonucleotide Therapeutics Market By Application (2017-2022)
9.3.5. India
9.3.5.1.India Antisense Oligonucleotide Therapeutics Market and Growth Rate (2017-2022)
9.3.5.2.India Antisense Oligonucleotide Therapeutics Market By Type (2017-2022)
9.3.5.2.India Antisense Oligonucleotide Therapeutics Market By Application (2017-2022)
9.3.5. Southeast Asia
9.3.5.1.Southeast Asia Antisense Oligonucleotide Therapeutics Market and Growth Rate (2017-2022)
9.3.5.2.Southeast Asia Antisense Oligonucleotide Therapeutics Market By Type (2017-2022)
9.3.5.2.Southeast Asia Antisense Oligonucleotide Therapeutics Market By Application (2017-2022)
9.3.5. Rest of Asia-Pacific
9.3.5.1.Rest of Asia-Pacific Antisense Oligonucleotide Therapeutics Market and Growth Rate (2017-2022)
9.3.5.2.Rest of Asia-Pacific Antisense Oligonucleotide Therapeutics Market By Type (2017-2022)
9.3.5.2.Rest of Asia-Pacific Antisense Oligonucleotide Therapeutics Market By Application (2017-2022)
6.3. South America
10.3.1. South America Antisense Oligonucleotide Therapeutics Market and Growth Rate (2017-2022))
10.3.2. South America Antisense Oligonucleotide Therapeutics Market By Type (2017-2022)
10.3.2. South America Antisense Oligonucleotide Therapeutics Market By Application (2017-2022)
10.3.4. South America Antisense Oligonucleotide Therapeutics Market By Country (2017-2022)
10.3.5. Brazil
10.3.5.1.Brazil Antisense Oligonucleotide Therapeutics Market and Growth Rate (2017-2022)
10.3.5.2.Brazil Antisense Oligonucleotide Therapeutics Market By Type (2017-2022)
10.3.5.2.Brazil Antisense Oligonucleotide Therapeutics Market By Application (2017-2022)
10.3.5. Mexico
10.3.5.1.Mexico Antisense Oligonucleotide Therapeutics Market and Growth Rate (2017-2022)
10.3.5.2.Mexico Antisense Oligonucleotide Therapeutics Market By Type (2017-2022)
10.3.5.2.Mexico Antisense Oligonucleotide Therapeutics Market By Application (2017-2022)
10.3.5. Columbia
10.3.5.1.Columbia Antisense Oligonucleotide Therapeutics Market and Growth Rate (2017-2022)
10.3.5.2.Columbia Antisense Oligonucleotide Therapeutics Market By Type (2017-2022)
10.3.5.2.Columbia Antisense Oligonucleotide Therapeutics Market By Application (2017-2022)
10.3.5. Rest of South America
10.3.5.1.Rest of South America Antisense Oligonucleotide Therapeutics Market and Growth Rate (2017-2022)
10.3.5.2.Rest of South America Antisense Oligonucleotide Therapeutics Market By Type (2017-2022)
10.3.5.2.Rest of South America Antisense Oligonucleotide Therapeutics Market By Application (2017-2022)
6.3. Middle East and Africa
11.3.1. Middle East and Africa Antisense Oligonucleotide Therapeutics Market and Growth Rate (2017-2022))
11.3.2. Middle East and Africa Antisense Oligonucleotide Therapeutics Market By Type (2017-2022)
11.3.2. Middle East and Africa Antisense Oligonucleotide Therapeutics Market By Application (2017-2022)
11.3.4. Middle East and Africa Antisense Oligonucleotide Therapeutics Market By Country (2017-2022)
11.3.5. Saudi Arabia
11.3.5.1.Saudi Arabia Antisense Oligonucleotide Therapeutics Market and Growth Rate (2017-2022)
11.3.5.2.Saudi Arabia Antisense Oligonucleotide Therapeutics Market By Type (2017-2022)
11.3.5.2.Saudi Arabia Antisense Oligonucleotide Therapeutics Market By Application (2017-2022)
11.3.5. United Arab Emirates
11.3.5.1.United Arab Emirates Antisense Oligonucleotide Therapeutics Market and Growth Rate (2017-2022)
11.3.5.2.United Arab Emirates Antisense Oligonucleotide Therapeutics Market By Type (2017-2022)
11.3.5.2.United Arab Emirates Antisense Oligonucleotide Therapeutics Market By Application (2017-2022)
11.3.5. South Africa
11.3.5.1.South Africa Antisense Oligonucleotide Therapeutics Market and Growth Rate (2017-2022)
11.3.5.2.South Africa Antisense Oligonucleotide Therapeutics Market By Type (2017-2022)
11.3.5.2.South Africa Antisense Oligonucleotide Therapeutics Market By Application (2017-2022)
11.3.5. Rest of Middle East and Africa
11.3.5.1.Rest of Middle East and Africa Antisense Oligonucleotide Therapeutics Market and Growth Rate (2017-2022)
11.3.5.2.Rest of Middle East and Africa Antisense Oligonucleotide Therapeutics Market By Type (2017-2022)
11.3.5.2.Rest of Middle East and Africa Antisense Oligonucleotide Therapeutics Market By Application (2017-2022)
7. Company Profiles
7.1. Ionis Pharmaceuticals, Inc
7.1.1. Business Overview
7.1.1. Service Portfolio
7.1.1. Strategic Developments
7.1.1. Financial Overview
7.1. Sarpeta Therapeutics Inc.
7.1.1. Business Overview
7.1.1. Service Portfolio
7.1.1. Strategic Developments
7.1.1. Financial Overview
7.1. Biogen Inc
7.1.1. Business Overview
7.1.1. Service Portfolio
7.1.1. Strategic Developments
7.1.1. Financial Overview
7.1. Alnylam Pharmaceuticals, Inc
7.1.1. Business Overview
7.1.1. Service Portfolio
7.1.1. Strategic Developments
7.1.1. Financial Overview
7.1. ï‚·Antisense Therapeutics Limited
7.1.1. Business Overview
7.1.1. Service Portfolio
7.1.1. Strategic Developments
7.1.1. Financial Overview
7.1. Arrowhead Pharmaceuticals Inc.
7.1.1. Business Overview
7.1.1. Service Portfolio
7.1.1. Strategic Developments
7.1.1. Financial Overview
7.1. Enzon Pharmaceuticals, Inc
7.1.1. Business Overview
7.1.1. Service Portfolio
7.1.1. Strategic Developments
7.1.1. Financial Overview
7.1. Bio-Path Holdings, Inc
7.1.1. Business Overview
7.1.1. Service Portfolio
7.1.1. Strategic Developments
7.1.1. Financial Overview
7.1. GlaxoSmithKline PLC
7.1.1. Business Overview
7.1.1. Service Portfolio
7.1.1. Strategic Developments
7.1.1. Financial Overview
7.1. ï‚·Geron Corporation (Geron)
7.1.1. Business Overview
7.1.1. Service Portfolio
7.1.1. Strategic Developments
7.1.1. Financial Overview
7.1. Sarpeta Therapeutics Inc
7.1.1. Business Overview
7.1.1. Service Portfolio
7.1.1. Strategic Developments
7.1.1. Financial Overview
Research Methodology
We use both primary as well as secondary research for our market surveys, estimates and for developing forecast. Our research process commence by analyzing the problem which enable us to design the scope for our research study. Our research process is uniquely designed with enough flexibility to adjust according to changing nature of products and markets, while retaining core element to ensure reliability and accuracy in research findings. We understand both macro and micro-economic factors to evaluate and forecast different market segments.
Data Mining
Data is extensively collected through various secondary sources such as annual reports, investor presentations, SEC filings, and other corporate publications. We also refer trade magazines, technical journals, paid databases such as Factiva and Bloomberg, industry trade journals, scientific journals, and social media data to understand market dynamics and industry trends. Further, we also conduct primary research to understand market drivers, restraints, opportunities, challenges, and competitive scenario to build our analysis.
Data Collection Matrix
|
Data Collection Matrix |
Supply Side |
Demand Side |
|
Primary Data Sources |
|
|
|
Secondary Data Sources |
|
|
Market Modeling and Forecasting
We use epidemiology and capital equipment-based models to forecast market size of different segments at country and regional level.
- Epidemiology-based Forecasting Model: This method uses epidemiology data gathered through various publications and from physicians to estimate population of patients, flow of treatment of individual disease and therapies. The data collected through this method includes statics on incidence of disease, population suffering from disease, and treatment population. This method is used to understand:
- Number of patients for particular device or medical procedure and
- Repeated use of particular device depending on health and condition of patient
- Capital-based Forecasting Model: This method of forecasting is based on number of replacements, installed-based and new sales of capital equipment used in various healthcare and diagnostic centers. These three parameters are calculated and forecast is developed. Installation base is calculated as average number of units per facility; while sales for particular year is calculated from number of new and replace units. Secondary data is collected through various supply chain intermediaries and opinion leaders to arrive at installation and sales rate. These techniques help our analysts in validating market and developed market estimates and forecast.
We do forecast on basis of several parameters such as market drivers, market opportunities, industry trends government regulations, raw materials supply and trade dynamics to ensure relevance of forecast with market scenario. With increasing need to granulized information, we used bottom-up methodology for forecasting where we evaluate each regional segment differently and combined all forecast to develop final market forecast.
Data Validation
We believe primary research is a very important tool in analyzing and forecasting different markets. In order to make sure accuracy of our findings, our team conducts primary interviews at every stage of research to gain deep insights into current business environment and future trends and key developments in market. This includes use of various methods such as telephonic interviews, focus groups, face to face interviews and questionnaires to validate our research from all aspects. We validate our data through primary research from key industry leaders such as CEO, product managers, marketing managers, suppliers, distributors, and consumers are frequently interviewed. These interviews provide valuable insights which help us to have better market understanding besides validating our estimates and forecast.
Data Triangulation
Industry Analysis
|
Qualitative Data |
Quantitative Data (2017-2025) |
|
|